Esperion Therapeutics
ESPR
#7681
Rank
NZ$0.48 B
Marketcap
$2.47
Share price
-2.08%
Change (1 day)
-46.96%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): NZ$15.21 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are NZ$0.33 Billion. , an increase over its 2023 earnings that were of -NZ$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 NZ$13.15 M-104.99%
2023 -NZ$0.27 Billion-15.03%
2022 -NZ$0.32 Billion-20.61%
2021 -NZ$0.4 Billion84.28%
2020 -NZ$0.22 Billion35.75%
2019 -NZ$0.16 Billion-55.71%
2018 -NZ$0.36 Billion19.57%
2017 -NZ$0.3 Billion125.39%
2016 -NZ$0.14 Billion51.43%
2015 -NZ$86.37 Million36.45%
2014 -NZ$63.3 Million43.55%
2013 -NZ$44.1 Million145.26%
2012 -NZ$17.98 Million
2002 -NZ$51.26 Million-7.81%
2001 -NZ$55.6 Million15.03%
2000 -NZ$48.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.89 Billion-6,821.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.94 B 7,117.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$19.48 B 147,954.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$8.38 B 63,581.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$50.42 Million-483.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.36 Billion-2,769.90%๐Ÿ‡บ๐Ÿ‡ธ USA